跳至主要内容
临床试验/NCT07768475
NCT07768475进行中(未招募)不适用

A Prospective Study Comparing Visual Outcomes and Patient Satisfaction Following Implantation of the Clareon PanOptix Versus Tecnis Odyssey IOL in Patients Undergoing Cataract Surgery.

Nvision Laser Eye Centers4 个研究点 分布在 1 个国家目标入组 266 人开始时间: 2025年7月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
266
试验地点
4
主要终点
Binocular BCDVA

研究概览

简要总结

To evaluate visual outcomes and patient satisfaction following bilateral implantation of the Clareon PanOptix versus Tecnis Odyssey IOL in patients undergoing cataract surgery

详细描述

Multi-center, one-arm, ambispective pilot study with Odyssey IOL followed by a multi-center, prospective, randomized, two-arm, double-masked (subject and assessor), Clareon PanOptix vs TECNIS Odyssey comparative study with bilateral IOL implantation (endpoints or sample size may be modified after the pilot data analysis)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Willing and able to understand and sign informed consent
  • Willing and able to participate with all study testing
  • Adult patient diagnosed with age-related cataracts bilaterally
  • Planned bilateral cataract removal by phacoemulsification with bilateral implantation of the Clareon PanOptix/ Clareon PanOptix Toric or Tecnis Odyssey IOL/ Tecnis Odyssey IOL Toric (T3/4 or DRT150, DRT225)
  • Best monocular corrected distance visual acuity expected to be 0.1 logMAR (Snellen 20/25) or better in both eyes postoperatively as determined by surgeon
  • Residual astigmatism expected to be ≤ 0.50 diopters in both eyes postoperatively as determined by surgeon (After using either toric IOL or arcuate incision with laser)
  • Normal ocular findings aside from cataract

排除标准

  • HOA greater than 0.4 μm within central 4 mm
  • Corneal dystrophies, degenerations, irregular astigmatism or any corneal abnormality aside from regular astigmatism deemed to be of clinical significance by the surgeon.
  • Any pathologic conditions that might affect ease of cataract removal (pseudoexfoliation, posterior polar, etc) as determined by surgeon
  • Strabismus with or without amblyopia in either eye
  • Previous history of any ocular surgery including corneal refractive surgery
  • Presence of any macular disease, history of retinal detachment, or posterior segment abnormality deemed to be of clinical significance by the surgeon.
  • Presence of glaucoma
  • Presence of any acute or chronic systemic disease that would confound the results of this study as determined by the surgeon (e.g. uncontrolled diabetes, immunocompromise, autoimmune disease, etc).
  • Any planned simultaneous/combined procedures at time of cataract surgery (e.g. MIGs).
  • Any subjects with intraoperative complications, including vitreous loss, posterior capsular rupture, zonular dialysis, decentered or tilted IOL, diffuse corneal epithelial defect, and use of iris hooks or expanders, will be excluded from analysis.

研究组 & 干预措施

Clareon® PanOptix® IOL models CNWTT0 and CNWTTx, x=3 & 4 (BLF)

Active Comparator

One of 2 IOLs being used in the study

干预措施: Intraocular Lens Implant (Device)

Tecnis® Odyssey® IOL models DRN00V, DRT150, DRT225

Active Comparator

One of 2 IOLs being used in the study

干预措施: Intraocular Lens Implant (Device)

结局指标

主要结局

Binocular BCDVA

时间窗: At Visit 2 Month 3

Binocular BCDVA at 4 m under photopic conditions

次要结局

  • Visual Acuity(Visit 2 Month 3)

研究者

发起方
Nvision Laser Eye Centers
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验